Cargando…
Asporin is a stromally expressed marker associated with prostate cancer progression
BACKGROUND: Prostate cancer shows considerable heterogeneity in disease progression and we propose that markers expressed in tumour stroma may be reliable predictors of aggressive tumour subtypes. METHODS: We have used Kaplan–Meier, univariate and multivariate analysis to correlate the expression of...
Autores principales: | Rochette, Annie, Boufaied, Nadia, Scarlata, Eleonora, Hamel, Lucie, Brimo, Fadi, Whitaker, Hayley C, Ramos-Montoya, Antonio, Neal, David E, Dragomir, Alice, Aprikian, Armen, Chevalier, Simone, Thomson, Axel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355923/ https://www.ncbi.nlm.nih.gov/pubmed/28152543 http://dx.doi.org/10.1038/bjc.2017.15 |
Ejemplares similares
-
Improving ultrasound-based prostate volume estimation
por: Aprikian, Saro, et al.
Publicado: (2019) -
Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression
por: Derderian, Seta, et al.
Publicado: (2023) -
Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
por: Zakaria, Ahmed S., et al.
Publicado: (2018) -
PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
por: Choucair, Khalil, et al.
Publicado: (2012) -
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer
por: Audet-Walsh, Étienne, et al.
Publicado: (2017)